Business Context and Reporting Period
Company: Medirom Healthcare Technologies Inc.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: May 29, 2026
Context: The filing reports the receipt of a notice from The Nasdaq Stock Market LLC regarding non-compliance with listing rules due to the failure to timely file the Form 20-F for the fiscal year ended December 31, 2025.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a regulatory notice regarding listing compliance rather than a financial results announcement.
Material Changes
- Listing Status: The Company received a notice on May 26, 2026, stating it is not in compliance with Nasdaq Listing Rule 5250(c)(1).
- Reason for Non-Compliance: Failure to timely file the Form 20-F for the fiscal year ended December 31, 2025.
- Immediate Effect: The notice has no immediate effect on the listing or trading of the Company's American Depositary Shares on Nasdaq.
Guidance, Outlook, and Risks
- Compliance Timeline: The Company has 60 calendar days (until July 27, 2026) to submit a plan to regain compliance.
- Extension Possibility: If a plan is accepted, Nasdaq may grant an exception of up to 180 calendar days (until November 11, 2026) to regain compliance by filing the Form 20-F.
- Appeal Rights: If the compliance plan is not accepted, the Company may appeal to a Hearings Panel under Nasdaq Listing Rule 5815(a).
- Management Intent: The Company intends to file its Form 20-F or provide a compliance plan on or before July 27, 2026.
- Risks: There is no assurance the Company will regain compliance within the specified periods or that Nasdaq will accept its plan. Forward-looking statements regarding future performance are subject to significant risks and uncertainties.
Investor Verification Checklist
- Verify the status of the Form 20-F for the fiscal year ended December 31, 2025, and confirm if it has been filed with the SEC.
- Monitor the Company's submission of a compliance plan to Nasdaq by the July 27, 2026 deadline.
- Check for any subsequent announcements regarding Nasdaq's acceptance or rejection of the compliance plan.
- Review the "Risk Factors" section of the Company's most recent Annual Report on Form 20-F (filed April 29, 2025) for detailed operational risks.